#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Jennifer Good Email
Co-Founder, President and CEO . Trevi Therapeutics
How to contact Jennifer Good
Join and see Jennifer's contact info for free!Current Roles
Employees:
29Revenue:
$4.5MAbout
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Founded in 2011, Trevi is headquartered in New Haven, CT.Trevi Therapeutics Address
195 Church StreetNew Haven, CT
United States